v3.25.2
Accrued Expenses
6 Months Ended
Jun. 30, 2025
Accrued Expenses  
Accrued Expenses

Note 3. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

June 30, 

December 31, 

    

2025

    

2024

    

Clinical trial expenses

$

1,730,818

$

1,135,542

Other

 

1,052,331

 

1,223,797

Total

$

2,783,149

$

2,359,339